McKeith, IG, Dickson, DW, Lowe, J, Emre, M, O'Brien, JT, Feldman, H, et al.
Diagnosis and management of dementia with Lewy bodies – third
report of the DLB consortium. Neurology
2005; 65: 1863–72.
O'Brien, JT, McKeith, IG, Walker, Z, Tatsch, K, Booij, J, Darcourt, J, et al.
Diagnostic accuracy of I-123-FP-CIT SPECT in possible
dementia with Lewy bodies. Br J
2009; 194: 34–9.
Litvan, I, Bhatia, KP, Burn, DJ, Goetz, CG, Lang, AE, McKeith, I, et al.
SIC Task force appraisal of clinical diagnostic criteria for
Parkinsonian disorders. Mov Disord
2003; 18: 467–86.
Nelson, PT, Jicha, GA, Kryscio, RJ, Abner, EL, Schmitt, FA, Cooper, G, et al.
Low sensitivity in clinical diagnoses of dementia with Lewy
bodies. J Neurology
2010; 257: 359–66.
Piggott, MA, Marshall, EF, Thomas, N, Lloyd, S, Court, JA, Jaros, E, et al.
Striatal dopaminergic markers in dementia with Lewy bodies,
Alzheimer's and Parkinson's diseases: rostrocaudal
1999; 122: 1449–68.
Walker, RWH, Walker, Z.
Dopamine transporter single photon emission computerized
tomography in the diagnosis of dementia with Lewy bodies.
Walker, Z, Jaros, E, Walker, RWH, Lee, L, Costa, DC, Livingston, G, et al.
Dementia with Lewy bodies: a comparison of clinical
diagnosis, FP-CIT single photon emission computed tomography imaging and
autopsy. J Neurol Neurosurg Psychiatry
2007; 78: 1176–81.
McKeith, I, O'Brien, J, Walker, Z, Tatsch, K, Booij, J, Darcourt, J, et al.
Sensitivity and specificity of dopamine transporter imaging
with (123)I-FP-CIT SPECT in dementia with Lewy bodies: a phase III,
multicentre study. Lancet Neurology
2007; 6: 305–13.
Boot, BP, McDade, EM, McGinnis, SM, Boeve, BF.
Treatment of dementia with Lewy bodies.
Curr Treat Options Neurol
2013; 15: 738–64.
Ballard, C, Grace, J, McKeith, I, Holmes, C.
Neuroleptic sensitivity in dementia with Lewy bodies and
Alzheimer's disease. Lancet
1998; 351: 1032–3.
Pakrasi, S, Mukaetova-Ladinska, EB, McKeith, IG, O'Brien, JT.
Clinical predictors of response to acetyl cholinesterase
inhibitors: experience from routine clinical use in
Newcastle. Int J Geriatr Psychiatry
2003; 18: 879–86.
Matsunaga, S, Kishi, T, Iwata, N.
Memantine for Lewy body disorders: systematic review and
meta-analysis. Am J Geriatr Psychiatry
2013 Dec 4 (Epub ahead of print).
Walker, Z, McKeith, I, Rodda, J, Qassem, T, Tatsch, K, Booij, J, et al.
Comparison of cognitive decline between dementia with Lewy
bodies and Alzheimer's disease: a cohort study.
Bostrom, F, Jonsson, L, Minthon, L, Londos, E.
Patients with Lewy body dementia use more resources than
those with Alzheimer's disease. Int J Geriatr
2007; 22: 713–9.
Bostrom, F, Jonsson, L, Minthon, L, Londos, E.
Patients with dementia with Lewy bodies have more impaired
quality of life than patients with Alzheimer disease.
Alzheimer Dis Assoc Disord
2007; 21: 150–4.
Folstein, MF, Folstein, SE, Mchugh, PR.
Mini-Mental State - practical method for grading cognitive
state of patients for clinician. J Psychiatric
1975; 12: 189–98.
Unified Parkinson's Disease Rating Scale. Recent Developments in
Parkinson's Disease: 153–63.
Mioshi, E, Dawson, K, Mitchell, J, Arnold, R, Hodges, JR.
The Addenbrooke's Cognitive Examination Revised (ACE-R): a
brief cognitive test battery for dementia screening.
Int J Geriatr Psychiatry
2006; 21: 1078–85.
Cummings, JL, Mega, M, Gray, K, Rosenbergthompson, S, Carusi, DA, Gornbein, J.
The Neuropsychiatric Inventory – comprehensive assessment of
psychopathology in dementia. Neurology
1994; 44: 2308–14.
Walker, MP, Ayre, GA, Cummings, JL, Wesnes, K, McKeith, IG, O'Brien, JT, et al.
The Clinician Assessment of Fluctuation and the One Day
Fluctuation Assessment Scale. Two methods to assess fluctuating confusion
in dementia. Br J Psychiatry
2000; 177: 252–6.
Sheikh, JI, Yesavage, JA.
Geriatric Depression Scale (GDS): Recent Evidence and Development of
a Shorter Version. Clinical Gerontology: A Guide to Assessment and
Intervention: 165–73. The Haworth
Filippi, L, Manni, C, Pierantozzi, M, Brusa, L, Danieli, R, Stanzione, P, et al.
123I-FP-CIT semi-quantitative SPECT detects preclinical
bilateral dopaminergic deficit in early Parkinson's disease with
unilateral symptoms. Nucl Med Commun
2005; 26: 421–6.
Kemp, PM, Clyde, K, Holmes, C.
Impact of I-123-Fp-Cit (Datscan) Spect on the diagnosis and
management of patients with dementia with Lewy bodies: a retrospective
study. Nucl Med Commun
Morgan, S, Kemp, P, Booij, J, Costa, DC, Padayachee, S, Lee, L, et al.
Differentiation of frontotemporal dementia from dementia with
Lewy bodies using FP-CIT SPECT. J Neurol
2012; 83: 1063–70.
Colloby, SJ, McParland, S, O'Brien, JT, Attems, J.
Neuropathological correlates of dopaminergic imaging in
Alzheimer's disease and Lewy body dementias.
2012; 135: 2798–808.
Siepel, FJ, Rongve, A, Buter, TC, Beyer, MK, Ballard, CG, Booij, J, et al.
(123I)FP-CIT SPECT in suspected dementia with Lewy bodies: a
longitudinal case study. BMJ Open
National Institute for Health and Care Excellence.
Supporting People with Dementia and their Carers in Health and
Social Care. NICE Clinical Guideline 42.
National Institute for Health and Care